Skip to main content
Sign In

Warren Capell, M.D.

Associate Professor of Medicine Director, Colorado Multiple Institutional Review Board

Dr. Capell joined the faculty in the Department of Medicine in the Division of Endocrinology in 2005.   Prior to that, he received his undergraduate education at Pomona College in Claremont, CA where he received a bachelor of arts in 1992. He then attended the University of Washington in Seattle, WA where he received his medical degree in 1996. He went on to do his internship and residency in Internal Medicine at the University of Colorado Health Sciences Center in Denver, CO from 1996 to 1999.  He remained at the University of Colorado Health Sciences Center for a fellowship in Endocrinology, which he completed in 2003.  Dr. Capell has also been on staff at Denver Health Medical Center in Denver, CO since 2005 as a clinical Endocrinologist. Since 2011, he has been serving as the Director of the Colorado Multiple Institutional Review Board (COMIRB), the IRB for University of Colorado Denver and its affiliate institutions.


Selected Publications

  1. Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.
    Capell WH, Schlaepfer IR, Wolfe P, Watson PA, Bessesen DH, Pagliassotti MJ, Eckel RH.
    Am J Physiol Endocrinol Metab. 2010 Oct;299(4):E576-83. Epub 2010 Jul 13.
  2. Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet.
    Hernandez TL, Sutherland JP, Wolfe P, Allian-Sauer M, Capell WH, Talley ND, Wyatt HR, Foster GD, Hill JO, Eckel RH.
    Am J Clin Nutr. 2010 Mar;91(3):578-85. Epub 2010 Jan 27.
  3. Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.
    Linnebur SA, Capell WH, Saseen JJ, Wolfe P, Eckel RH.
    J Clin Lipidol. 2007 Dec;1(6):626-33. Epub 2007 Oct 18.
  4. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.
    Hernandez TL, Capell WH, Wolfe P, Gerard LA, Eckel RH.
    Am J Cardiol. 2006 Dec 15;98(12):1656-9. Epub 2006 Oct 25.
  5. Severe hypertriglyceridemia with a history of treatment failure.
    Capell WH, Eckel RH.
    Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):53-8; quiz 59.
  6. Treatment of hypertriglyceridemia.
    Capell WH, Eckel RH.
    Curr Diab Rep. 2006 Jun;6(3):230-40. Review.
  7. Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance.
    Schlaepfer IR, Pulawa LK, Ferreira LD, James DE, Capell WH, Eckel RH.
    J Lipid Res. 2003 Jun;44(6):1174-81. Epub 2003 Apr 16.
  8. Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia.
    Capell WH, DeSouza CA, Poirier P, Bell ML, Stauffer BL, Weil KM, Hernandez TL, Eckel RH.
    Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):307-13.


​Coming Soon!​

Medical Schools
MD, University of Washington School of Medicine (1996)

Internship and Residency
Internal Medicine at the University of Colorado Health Sciences Center (1996-1999)

Endocrinology, University of Colorado Health Sciences Center (completed in 2003)